|
1
|
Di Bonito P, Grasso F, Mochi S, Accardi L,
Donà MG, Branca M, Costa S, Mariani L, Agarossi A, Ciotti M, et al:
Serum antibody response to human papillomavirus (HPV) infections
detected by a novel ELISA technique based on denatured recombinant
HPV16 L1, L2, E4, E6 and E7 proteins. Infect Agent Cancer. 1:62006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chelimo C, Wouldes TA, Cameron LD and
Elwood JM: Risk factors for and prevention of human
papillomaviruses (HPV), genital warts and cervical cancer. J
Infect. 66:207–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muñoz N, Bosch FX, de Sanjosé S, Herrero
R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ:
International Agency for Research on Cancer Multicenter Cervical
Cancer Study Group: Epidemiologic classification of human
papillomavirus types associated with cervical cancer. N Engl J Med.
348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeCaprio JA: Human papillomavirus type 16
E7 perturbs DREAM to promote cellular proliferation and mitotic
gene expression. Oncogene. 33:4036–4038. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Delury CP, Marsh EK, James CD, Boon SS,
Banks L, Knight GL and Roberts S: The role of protein kinase A
regulation of the E6 PDZ-binding domain during the
differentiation-dependent life cycle of human papillomavirus type
18. J Virol. 87:9463–9472. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ruttkay-Nedecky B, Jimenez Jimenez AM,
Nejdl L, Chudobova D, Gumulec J, Masarik M, Adam V and Kizek R:
Relevance of infection with human papillomavirus: The role of the
p53 tumor suppressor protein and E6/E7 zinc finger proteins
(Review). Int J Oncol. 43:1754–1762. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McGraw SL and Ferrante JM: Update on
prevention and screening of cervical cancer. World J Clin Oncol.
5:744–752. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zumbach K, Kisseljov F, Sacharova O,
Shaichaev G, Semjonova L, Pavlova L and Pawlita M: Antibodies
against oncoproteins E6 and E7 of human papillomavirus types 16 and
18 in cervical-carcinoma patients from Russia. Int J Cancer.
85:313–318. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chouhy D, Gil LB, Nocito AL, Wojdyla D,
Ornella L, Cittadini J, Gardiol D and Giri AA: Development and
evaluation of a colorimetric PCR system for the detection and
typing of human papillomaviruses. Int J Mol Med. 18:995–1003.
2006.PubMed/NCBI
|
|
10
|
Cheng J, Bian M, Cong X, Sun A, Li M, Ma
L, Chen Y and Liu J: Evaluation of a novel real-time fluorescent
polymerase chain reaction assay for high-risk human papilloma virus
DNA genotypes in cytological cervical screening. Biomed Rep.
1:280–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu X, Chen G, Qiu J, Lu J, Zhu W, Chen J,
Zhuo S and Yan J: Visualization of basement membranes in normal
breast and breast cancer tissues using multiphoton microscopy.
Oncol Lett. 11:3785–3789. 2016.PubMed/NCBI
|
|
12
|
Paavonen J, Jenkins D, Bosch FX, Naud P,
Salmerón J, Wheeler CM, Chow SN, Apter DL, Kitchener HC,
Castellsague X, et al: Efficacy of a prophylactic adjuvanted
bivalent L1 virus-like-particle vaccine against infection with
human papillomavirus types 16 and 18 in young women: An interim
analysis of a phase III double-blind, randomised controlled trial.
Lancet. 369:2161–2170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pyne M, Law C, Hillyard D and Schlaberg R:
Testing and genotyping of high-risk human papillomavirus by the
cobas HPV Test and the Hybrid Capture 2 high-risk HPV DNA test
using cervical and vaginal samples. J Clin Microbiol. 52:1720–1723.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Munagala R, Kausar H, Munjal C and Gupta
RC: Withaferin A induces p53-dependent apoptosis by repression of
HPV oncogenes and upregulation of tumor suppressor proteins in
human cervical cancer cells. Carcinogenesis. 32:1697–1705. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen CL, Hsieh FC, Lieblein JC, Brown J,
Chan C, Wallace JA, Cheng G, Hall BM and Lin J: Stat3 activation in
human endometrial and cervical cancers. Br J Cancer. 96:591–599.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Perkins RB, Anderson BL, Gorin SS and
Schulkin JA: Challenges in cervical cancer prevention: A survey of
U.S. obstetrician-gynecologists. Am J Prev Med. 45:175–181. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ratnam S, Coutlee F, Fontaine D, Bentley
J, Escott N, Ghatage P, Gadag V, Holloway G, Bartellas E, Kum N, et
al: Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA
assay in comparison with that of the Hybrid Capture 2 test for
identification of women at risk of cervical cancer. J Clin
Microbiol. 48:2779–2785. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao FH, Jeronimo J, Qiao YL, Schweizer J,
Chen W, Valdez M, Lu P, Zhang X, Kang LN, Bansil P, et al: An
evaluation of novel, lower-cost molecular screening tests for
humanpapillomavirus in rural China. Cancer Prev Res (Phila).
6:938–948. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hovland S, Arbyn M, Lie AK, Ryd W, Borge
B, Berle EJ, Skomedal H, Kadima TM, Kyembwa L, Billay EM, et al: A
comprehensive evaluation of the accuracy of cervical pre-cancer
detection methods in a high-risk area in East Congo. Br J Cancer.
102:957–965. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Waldstrøm M and Ornskov D: Clinical
performance of a human papillomavirus messenger RNA test (Aptima
HPV Assay) on residual material from archived 3-year-old PreservCyt
samples with low-grade squamous intraepithelial lesion. Arch Pathol
Lab Med. 135:1052–1056. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Benevolo M, Vocaturo A, Caraceni D, French
D, Rosini S, Zappacosta R, Terrenato I, Ciccocioppo L, Frega A and
Rossi Giorgi P: Sensitivity, specificity, and clinical value of
human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for
cervical cytology and HPV DNA test. J Clin Microbiol. 49:2643–2650.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stoler MH, Wright TC Jr, Cuzick J, Dockter
J, Reid JL, Getman D and Giachetti C: APTIMA HPV assay performance
in women with atypical squamous cells of undetermined significance
cytology results. Am J Obstet Gynecol. 208:144.e1–8. 2013.
View Article : Google Scholar
|
|
23
|
Castro Perez S, Iñarrea Fernández A,
González Lamas MJ, Diez Sarán MT, Lama Cid A, Martín Alvarez MJ,
Mosquera Pato M, López-Miragaya I, Estévez N, Piñón Torres J and
Navarro Oña M: Human papillomavirus (HPV) E6/E7 mRNA as a triage
test after detection of HPV 16 and HPV 18 DNA. J Med Virol.
85:1063–1068. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Singh GK, Azuine RE and Siahpush M: Global
inequalities in cervical cancer incidence and mortality are linked
to deprivation, low socioeconomic status, and human development.
Int J MCH AIDS. 1:17–30. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Knaul FM, Bhadelia A, Gralow J,
Arreola-Ornelas H, Langer A and Frenk J: Meeting the emerging
challenge of breast and cervical cancer in low- and middle-income
countries. Int J Gynaecol Obstet. 119 Suppl 1:S85–S88. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thun MJ, DeLancey JO, Center MM, Jemal A
and Ward EM: The global burden of cancer: Priorities for
prevention. Carcinogenesis. 31:100–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lei T, Mao WM, Lei TH, Dai LQ, Fang L,
Chen WQ and Zhang SW: Incidence and mortality trend of cervical
cancer in 11 cancer registries of China. Chin J Cancer Res.
1:10–14. 2011. View Article : Google Scholar
|
|
28
|
Shepherd JH: Cervical cancer. Best Pract
Res Clin Obstet Gynaecol. 26:293–309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sangoi AR, Rogers WM, Longacre TA, Montoya
JG, Baron EJ and Banaei N: Challenges and pitfalls of morphologic
identification of fungal infections in histologic, and cytologic
specimens: A ten-year retrospective review at a single institution.
Am J Clin Pathol. 131:364–375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen H, Shu HM, Chang ZL, Wang ZF, Yao HH,
Zhu HM, Lu TM, Ma QY and Yang BL: Efficacy of Pap test in
combination with ThinPrep cytological test in screening for
cervical cancer. Asian Pac J Cancer Prev. 13:1651–1655. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu XY, Zhao W, Li GJ, Jin XY and Li YZ:
Clinical significance of combined detection of thinprep cytology
test and high risk human papillomavirus hybrid capture 2 assay in
the screening and recurrence predication of cervical
intraepithelial neoplasia. Zhonghua Yi Xue Za Zhi. 92:2503–2505.
2012.(In Chinese). PubMed/NCBI
|
|
33
|
Ratnam S, Coutlee F, Fontaine D, Bentley
J, Escott N, Ghatage P, Gadag V, Holloway G, Bartellas E, Kum N, et
al: Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2
Assay but more specific at detecting cervical precancer and cancer.
J Clin Microbiol. 49:557–564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Peh WL, Middieton K, Christensen N,
Nicholls P, Egawa K, Sotlar K, Brandsma J, Percival A, Lewis J, Liu
WJ and Doorbar J: Life cycle heterogeneity in animal models of
human papillomavirus-associated disease. J Virol. 76:10401–10416.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bodily JM, Mehta KP, Cruz L, Meyers C and
Laimins LA: The E7 open reading frame acts in cis and in trans to
mediate differentiation-dependent activities in the human
papillomavirus type 16 life cycle. J Virol. 85:8852–8862. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schweizer J, Lu PS, Mahoney CW,
Berard-Bergery M, Ho M, Ramasamy V, Silver JE, Bisht A, Labiad Y,
Peck RB, et al: Feasibility study of a human papillomavirus E6
oncoprotein test for diagnosis of cervical precancer and cancer. J
Clin Microbiol. 48:4646–4648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cuzick J, Bergeron C, von Knebel Doeberitz
M, Gravitt P, Jeronimo J, Lorincz AT, Meijer J L M C,
Sankaranarayanan R, Snijders J F P and Szarewski A: New
technologies and procedures for cervical cancer screening. Vaccine.
30 Suppl 5:F107–F116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Achour M, Ben Younes R, Kochbati L, Kahla
S, Zeghal D, Maalej M, Zouari F and Oueslati R: Production of
recombinant proteins GST L1, E6 and E7 tag HPV 16 for antibody
detection of tunisian cervical cancer patients. African J
Biotechnol. 8:369–374. 2009.
|
